News | April 17, 2026
NIFTY Pharma shows stable trend amid cautious market sentiment
Muted movement reflects consolidation phase as investors await earnings triggers
Muted movement reflects consolidation phase as investors await earnings triggers
The rating on senior secured notes issued by Biocon Biologics Global PLC was also upgraded to ‘BB+.’
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
The stability is led by healthy demand in the domestic and emerging markets
Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
To boost compostable packaging, resin innovation, and supply chain speed
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
Subscribe To Our Newsletter & Stay Updated
